Others Flashcards
Most common feature of MEN1 (occurs in 90%)
Primary hyperparathyroidism
MEN1
Pancreatic tumors
Parathyroid
Pituitary
Medical treatment MEN1 Dillinger Ellison syndrome goal and drug of choice
Basal acid output
Treatment of disseminated gastrinomas
Chemo Streptomycin 5- fluorouracil Hormone therapy Ocreotide Lanreotide
MC pancreatic tumors in MEN 1 (>50%)
Gastrinomas
Characteristic clinical manifestations of glucagon a
Skin rash (necrolytic migratory erythema)
Weight loss
Anemia
Stomatitis
Medical treatment of insulinoma
Frequent carbohydrate meals
Diazoxide
Ocreotide
Reported in few patients with MEN1
(+) watery diarrhea
Hypokalemia
Achlorydia
VIPomas (vasoactive intestinal peptide)
Aka
VERNER MORRISON SYNDROME
VIPomas
WDHA (watery diarrhea, hypokalemia and achlorydia) syndrome
Dx of VIPoma
Stool volume >0.5-1L / day during a fast
Markedly increased plasma VIP concentration
The most common enterobacter iv NET associated with MEN1
Nonfunctioning pancreatic NET
Criteria metabolic syndrome
Central obesity waist circumference >102 M, >88 cm
Hypertriglyceridemia >=150
Low HDL =130 or >=85 diastolic
FPG >= 100 mg/dl
Hypertension 130/80
3 or more!!!
Most accepted and unifying hypothesis to describe the pathophysiology of metabolic syndrome
Insulin resistance
Onset of insulin resistance in metabolic syndrome is heralded by
Post prandial hyperinsulinemia
Excellent marker of the insulin resistant condition
Hypertriglyceridemia